AWAITS: A Web-based E-health Application for Active Illicit Opioid Users

NCT03402672 | Completed

• 1 other identifier: 2017-1074-2
• Study Type: interventional
• Target: 24
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this research study is to:

1. 1.assess how participants like the AWAITS e-health application as measured by their feedback on the intervention
2. 2.test the impact of AWAITS on knowledge about opioid overdose and risk-reduction strategies.
3. 3.assess the proportion of participants who accept a list of local treatment providers
4. 4.test the impact of AWAITS on interest in being tested for HCV/HIV.

Conditions

Opioid-use Disorder; IV Drug Usage; Overdose; Drug Addiction; Substance Use Disorders

Outcome Measures

Primary Outcomes (1)

• 3 sections of the OOTAS (signs of overdose, how to respond to an overdose, and MAT)

  To test the impact of AWAITS on knowledge about opioid overdose

  Day 1

Secondary Outcomes (2)

• Feedback on AWAITS

  Day 1

• Acceptance of list of MAT providers

  Day 1

Study Arms (1)

AWAITS

EXPERIMENTAL

Participants who meet criteria will receive the AWAITS self-administered, e-health application intervention.

Other: self-administered, e-health application

Interventions

self-administered, e-health application OTHER

AWAITS is a self-administered, e-health application and includes short videos in which patients who are successfully engaged in MAT discuss what they wish they had known about MAT when they were actively using. The intervention is designed to maximize "scalability" - the administration would entail handing an electronic device (e.g., tablet, laptop, etc.) to an individual who would then self-administer the intervention.

AWAITS

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• At least 18 years of age
• Not enrolled in MAT per self-report
• Self-reports illicit opioid use

You may not qualify if:

• \. Does not acknowledge reviewing "Information Sheet for Research" within REDCap

Sponsors & Collaborators

• University of Cincinnati: lead

Study Sites (1)

University of Cincinnati Addiction Sciences Division

Cincinnati, Ohio, 45229, United States

Location

MeSH Terms

Conditions

Opioid-Related Disorders; Drug Overdose; Substance-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related Disorders; Chemically-Induced Disorders; Mental Disorders; Prescription Drug Misuse; Drug Misuse

Study Officials

• Theresa Winhusen, PhD

  University of Cincinnati

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: January 10, 2018
• First Posted: January 18, 2018
• Study Start: November 8, 2017
• Primary Completion: June 21, 2018
• Study Completion: June 21, 2018
• Last Updated: April 10, 2019

Record last verified: 2019-04

Locations

US (1)